ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JOHN GLENN MD

84 E. STATE ST ST. MARY'S HOSPITAL, GLOVERSVILLE FAM HLTH CNTR

Gloversville | New York | 12078

(518) 773-8894

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 131

$825K Total Retail Price of All Prescriptions

Rank: 11 out of 131

491 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 491 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 7,654 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 558 466 1 1
OMEPRAZOLE 406 318 2 4
LISINOPRIL 348 255 3 6
AMLODIPINE BESYLATE 335 283 4 2
METOPROLOL TARTRATE 324 257 5 7
FUROSEMIDE 294 241 6 3
HYDROCODONE-ACETAMINOPHEN 270 149 S3 7 13
METFORMIN HCL 265 196 8 8
LEVOTHYROXINE SODIUM 258 222 9 5
HYDROCHLOROTHIAZIDE 220 148 10 12
METOPROLOL SUCCINATE 174 141 11 10
ATENOLOL 158 129 12 14
ATORVASTATIN CALCIUM 134 119 13 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 133 115 14 70
GABAPENTIN 119 65 15 20
ADVAIR DISKUS 116 94 16 33
ALLOPURINOL 115 92 17 52
CRESTOR 110 96 18 19
WARFARIN SODIUM 106 88 19 9
ZOLPIDEM TARTRATE 104 91 20 15
DIOVAN 99 81 21 30
NEXIUM 97 56 22 16
CELEBREX 95 76 23 108
JANUMET 93 85 24 121
NOVOLOG MIX 70-30 FLEXPEN 83 71 25 269
PRAVASTATIN SODIUM 82 71 26 46
GLIMEPIRIDE 82 76 26 81
LYRICA 81 44 28 103
ALENDRONATE SODIUM 79 62 29 23
DIOVAN HCT 79 78 29 62
TRAMADOL HCL 78 40 31 31
DONEPEZIL HCL 77 77 32 17
IBUPROFEN 74 42 33 48
KLOR-CON M20 70 58 34 113
TAMSULOSIN HCL 70 70 34 24
CYCLOBENZAPRINE HCL 70 30 R 34 193
DIGOXIN 69 65 37 49
PROAIR HFA 69 35 37 65
LEVOFLOXACIN 64 51 39 96
VENTOLIN HFA 64 49 39 85
AZITHROMYCIN 64 53 39 38
SPIRIVA 62 50 42 57
JANUVIA 58 51 43 32
GLYBURIDE 58 43 R 43 55
CLOPIDOGREL 57 36 45 28
SERTRALINE HCL 57 42 45 27
ISOSORBIDE MONONITRATE ER 56 56 47 45
PEN NEEDLE 56 53 47 318
AMITRIPTYLINE HCL 56 35 R 47 207
CYMBALTA 55 41 50 90
LOSARTAN POTASSIUM 55 50 50 21
FENOFIBRATE 55 34 50 124
LOVAZA 55 26 50 41
TRICOR 54 25 54 203
RAMIPRIL 52 28 55 73
PREDNISONE 52 45 55 51
NAPROXEN 50 39 57 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.